Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Assets (2016 - 2025)

Historic Assets for Veracyte (VCYT) over the last 14 years, with Q3 2025 value amounting to $1.4 billion.

  • Veracyte's Assets rose 727.56% to $1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 billion, marking a year-over-year increase of 727.56%. This contributed to the annual value of $1.3 billion for FY2024, which is 1660.49% up from last year.
  • According to the latest figures from Q3 2025, Veracyte's Assets is $1.4 billion, which was up 727.56% from $1.3 billion recorded in Q2 2025.
  • In the past 5 years, Veracyte's Assets registered a high of $1.4 billion during Q3 2025, and its lowest value of $1.0 billion during Q1 2021.
  • Moreover, its 5-year median value for Assets was $1.2 billion (2022), whereas its average is $1.2 billion.
  • In the last 5 years, Veracyte's Assets skyrocketed by 30018.97% in 2021 and then plummeted by 509.11% in 2022.
  • Veracyte's Assets (Quarter) stood at $1.2 billion in 2021, then decreased by 2.64% to $1.2 billion in 2022, then dropped by 3.59% to $1.1 billion in 2023, then grew by 16.6% to $1.3 billion in 2024, then increased by 5.21% to $1.4 billion in 2025.
  • Its last three reported values are $1.4 billion in Q3 2025, $1.3 billion for Q2 2025, and $1.3 billion during Q1 2025.